No abstract

A total of 103 patients (40 with pure sensory disturbances, 63 with sensory and motor deficits) with ulnar nerve lesions at the elbow were examined neurophysiologically. The measurement of motor conduction velocity across the cubital tunnel alone did not completely localize the lesion. The latency to an ulnar-innervated flexor muscle was of outstanding importance. The measurement of amplitudes was only rarely of localizing significance. The results of sensory recording proved to be important in patients with pure sensory disturbances. In cases with additional motor deficits, sensory recordings were too often abnormal in all segments of the ulnar nerve to be of substantial localizing value.

The findings support the hypothesis that muscle tension in rheumatic patients results from overactivity of the sympathetic system (or part of it). Even in clinically localized pain syndromes, muscle damping is often increased in the legs. The test is valuable for quantitating muscle tension and the effectiveness of therapeutic methods.

No abstract

SUMMARY An analysis is presented of 220 cases of possible neurotoxic reactions to halogenated hydroxyquinolines reported from outside Japan. In 80 cases insufficient information was available for adequate comment and in 29 a relationship to the administration of clioquinol could be excluded. Of the remainder, a relationship to clioquinol was considered probable in 42 and possible in 69 cases. In six of the probable cases the neurological disturbance consisted of an acute reversible encephalopathy usually related to the ingestion of a high dose of clioquinol over a short period. The most common manifestation, observed in 15 further cases, was isolated optic atrophy. This was most frequently found in children, many of whom had received clioquinol as treatment for acrodermatitis enteropathica. In the remaining cases, a combination of myelopathy, visual disturbance, and peripheral neuropathy was the most common manifestation. Isolated myelopathy or peripheral neuropathy, or these manifestations occurring together, were infrequent. The onset of all manifestations (except toxic encephalopathy) was usually subacute, with subsequent partial recovery. Older subjects tended to display more side effects. The full syndrome of subacute myelo-optic neuropathy was more frequent in women, but they tended to have taken greater quantities of the drug.